This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mersana Therapeutics, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Donna M Jarlenski: Innovator in Targeted Cancer Therapies
Introduction
Donna M Jarlenski is a prominent inventor based in New Haven, CT (US). She has made significant contributions to the field of cancer treatment through her innovative work in antibody-drug conjugates. Her research focuses on targeted therapies that aim to improve patient outcomes in oncology.
Latest Patents
Donna holds a patent for "NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof." This patent outlines dosing regimens for targeted NaPi2b antibody-drug conjugates specifically designed for treating cancer. Her work in this area represents a crucial advancement in the development of more effective cancer therapies.
Career Highlights
Donna is currently associated with Mersana Therapeutics, Inc., where she continues to push the boundaries of cancer research. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking innovations.
Collaborations
Some of her notable coworkers include Eric P Hailman and Donald A Bergstrom. Their collective expertise enhances the research environment and fosters the development of new therapeutic strategies.
Conclusion
Donna M Jarlenski's contributions to targeted cancer therapies exemplify the impact of innovative thinking in medicine. Her work not only advances scientific knowledge but also holds the potential to improve the lives of cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile